Semarion

Semarion is a spin-out from Cambridge University with a mission to accelerate the pace of drug discovery. We are revolutionising adherent cell screening to produce better data, faster. Our proprietary SemaCyte® cell microcarrier platform leverages novel materials physics to deliver assay flexibility, miniaturisation, and multiplexing with existing tools and workflows. Our microcarriers function as ultra-miniaturized, magnetically steerable wells which can carrier small colonies of cells to enable more powerful assaying workflows and new experimental paradigms.